Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.7.0.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating Activities:    
Net Loss $ (1,745,308) $ (334,705)
Adjustments to reconcile net loss from operations to net cash used in operating activities:    
Stock-based compensation 229,631 185,456
Amortization of deferred financing cost 122,804
Warrant revaluation (1,253,854)
Changes in operating working capital items:    
Accounts receivable - fees and reimbursable project costs 300,820 (13,822)
Prepaid expenses and other assets (84,134) (308,438)
Accounts payable and accrued liabilities 78,262 505,498
Deferred lease abandonment liability (42,164) (95,008)
Net Cash Used In Operating Activities (1,140,089) (1,314,873)
Investing Activities:    
Patent costs (42,889) (61,599)
Net Cash Used In Investing Activities (42,889) (61,599)
Financing Activities:    
Net proceeds from the issuance of common stock 2,813,160 1,396,339
Proceeds from the issuance of note payable 135,000
Repayment of note payable (26,786)
Restricted cash (24)
Net Cash Provided by Financing Activities 2,813,136 1,504,553
Net Increase In Cash and Cash Equivalents 1,630,158 128,081
Cash and Cash Equivalents, Beginning of Period 3,584,877 623,184
Cash and Cash Equivalents, End of Period 5,215,035 751,265
Cash paid during the year:    
Interest paid 484
Income taxes paid
Non-Cash Financing Activity:    
Decrease in accrued liabilities - stock-based compensation 121,720
Accumulated preferred stock dividend $ 49,000